Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

Thrombosis and Haemostasis

Volumn 96, Issue 4, 2006, Pages 488-491

  Taher, Ali ^a   Isma'eel, Hussain ^a   Mehio, Ghassan ^a   Bignamini, Daniela ^b   Kattamis, Antonis ^c   Rachmilewitz, Eliezer A ^d   Cappellini, Maria Domencia ^b,e  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d WOLFSON MEDICAL CENTER   (Israel)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Thalassaemia intermedia; Thalassaemia major; Thrombosis

Indexed keywords

HEMOGLOBIN; ORAL CONTRACEPTIVE AGENT;

ADULT; ANEMIA; ARTERY THROMBOSIS; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CONTROLLED STUDY; EGYPT; FEMALE; GREECE; HUMAN; IRAN; ISRAEL; ITALY; JORDAN; LEBANON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SAUDI ARABIA; SEX DIFFERENCE; SPLENECTOMY; THALASSEMIA MAJOR; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ADULT; ANEMIA; ANTICOAGULANTS; BETA-THALASSEMIA; FEMALE; HUMANS; IRAN; MALE; MEDITERRANEAN REGION; PREVALENCE; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; SPLENECTOMY; THROMBOEMBOLISM;

EID: 33749872392     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-05-0267     Document Type: Article

References (18)

1. Clark BE, Them SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004; 26: 159-76.
2. Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 2004; 124: 264-74.
3. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995; 80: 58-68.
4. Camaschella C, Mazza U, Roetto A, et al. Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. Am J Hematol 1995; 48: 82-7.
5. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
6. Logothetis J, Constantoulakis M, Economidou J, et al. Thalassemia major (homozygous beta-thalassemia). a survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972; 22: 294-304.
7. Cappellini MD, Robbiolo L, Bottasso BM, et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467-73.
8. Taher A, Abou-Mourad Y, Abchee A, et al. Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin 2002; 26:107-12.
9. Zalloua PA, Shbaklo H, Mourad YA, et al. Incidence of thromboembolic events in Lebanese thalassemia intermedia patients. Thromb Haemost 2003; 89: 767-8.
10. Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology (Am Soc Hematol Educ Program) 2004;14-34.
11. Borgna-Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicentre study. Acta Haematol 1998; 99: 76-9.
12. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann NY Acad Sci 1998; 850: 227-31.
13. Moratelli S, De Sanctis V, Gemmati D, et al. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1999; 11 (Suppl 3): 915-21.
14. Gillis S, Cappellim MD, Goldfarb A, et al. Pulmonary thromboembolism in thalassemia intermedia patients. Haematologica 1999; 94: 959-60.
15. Visseren FL, Verkerk MS, van der Bruggen T, et al. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest 2002; 32 (Suppl 1): 84-90.
16. Butthep P, Rummavas S, Wisedpanichkij R, et al. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalasserma. Am J Hematol 2002; 70: 100-6.
17. Kyriakou DS, Alexandrakis MG, Kyriakou ES, et al. Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol 2001; 80: 577-83.
18. Fujita F, Lyass S, Otsuka K, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg 2003; 69: 951-6.